Clin2
NCT06408181Possibly a fitRecruiting

Aspirin to prevent pregnancy loss and preeclampsia

Pre-EclampsiaPregnancy Loss

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study tests whether taking a low dose of aspirin early in pregnancy can lower the risk of losing the baby or developing preeclampsia (a serious condition with high blood pressure). It is for women who have risk factors for these problems and are very early in pregnancy (less than 7 weeks).

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,150 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are pregnant and it has been less than 7 weeks since your last period or embryo transfer.
  • You are between 18 and 45 years old.
  • You have at least one risk factor for preeclampsia or pregnancy loss (such as a previous preeclampsia, diabetes, high blood pressure, or being a first-time mom).
  • You are willing to take a daily aspirin pill while pregnant.
  • You do not have any medical reason not to take aspirin (like a bleeding disorder or allergy).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04356326Recruiting· Phase 3
Aspirin to prevent complications in pregnancy with chronic high blood pressure

This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.

Bordeaux
NCT06281665Recruiting· Phase 4
Aspirin after preeclampsia: the TAP trial

This trial tests whether taking low-dose aspirin after giving birth can help people who had preeclampsia. It aims to see if aspirin can lower the risk of future heart problems.

Pittsburgh, Pennsylvania
NCT03667326Recruiting· Phase 2
Low-dose aspirin after severe preeclampsia

This Phase 2 study tests whether starting low-dose aspirin after delivery can help people who had severe preeclampsia. The goal is to see if this treatment is safe and beneficial in the weeks after birth.

New York, New York
NCT05709483Recruiting· Early Phase 1
Aspirin plan test to predict who avoids preeclampsia

This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.

New York, New York
NCT06826859Recruiting· Phase 1/Phase 2
Daily aspirin vs split dosing to prevent preeclampsia

This study compares taking a daily low-dose aspirin (a single pill) versus splitting the same dose into two smaller pills many hours apart to see which way better prevents preeclampsia in pregnant people who are at higher risk.

Philadelphia, Pennsylvania
NCT07665853Not yet recruiting· Phase 3
Aspirin timing study for preventing preeclampsia

This study looks at whether taking aspirin for a longer or shorter time during pregnancy can better prevent preeclampsia, a serious condition with high blood pressure. It is for pregnant women already taking daily aspirin and found to be at high risk.

Vienna

Hear when a new Pre-Eclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.